Arjun Deb, Md

This early-stage trial is testing whether a new antibody called AD-NP1 is safe to give to people. The antibody targets a protein called ENPP1, which may play a role in certain diseases. Healthy volunteers will receive either the antibody or a placebo (salt water) as a single intr…